Cancer site | Males | Females | ||
---|---|---|---|---|
Projected incidence rates | (R2) | Projected incidence rates | (R2) | |
2018 | 2018 | |||
Oropharyngeal | 3.7 | 0.03 | 2.8 | 0.04 |
Esophagus | 0.6 | 0.15 | 0.7 | 0.25 |
Stomach | 9.3 | 0.21 | 7.7 | 0.08 |
Colon | 17.1 | 0.26 | 10.9 | 0.03 |
Rectum | 4.4 | 0.50 | 5.9 | 0.32 |
Liver | 7.9 | 0.79* | 6.6 | 0.62 |
Gall bladder | 0.7 | 0.13 | 2.5 | 0.23 |
Pancreas | 5.9 | 0.33 | 2.3 | 0.08 |
Larynx | 7.9 | 0.26 | 2.0 | 0.29 |
Lung | 32.7 | 0.04 | 14.3 | 0.07 |
Bone | 3.8 | 0.19 | 1.1 | 0.15 |
Connective tissue | 0.4 | 0.07 | 1.6 | 0.03 |
Melanoma of the skin | 0.3 | 0.35 | 1.0 | <0.01 |
Prostate | 64.2 | 0.81* | ||
Testis and male genitalia | 0.5 | 0.37 | ||
Breast | 137.0 | 0.64* | ||
Cervix uteri | 5.8 | 0.09 | ||
Corpus uteri | 16.0 | 0.91* | ||
Ovary | 22.0 | 0.49* | ||
Bladder | 41.2 | 0.29 | 13.4 | 0.64 |
Kidney and urinary tract | 9.4 | 0.65 | 2.2 | 0.02 |
Brain and nervous system | 7.1 | 0.08 | 1.6 | 0.18 |
Thyroid | 7.0 | 0.72* | 14.7 | 0.92* |
Hodgkin disease | 4.3 | 0.01 | 4.9 | 0.24 |
Non-Hodgkin disease | 22.1 | 0.34 | 20.0 | 0.39 |
All sites | 296.0 | 0.67* | 339.5 | 0.75* |